Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $9.46, $0.15 better than the analyst estimate of $9.31. Revenue for the quarter came in at $41.9 billion versus the consensus estimate of $40.92 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.